Abstract
Rapid advances in gene expression microarray technology have enabled to discover molecular markers used for cancer diagnosis, prognosis, and prediction. One computational challenge with using microarray data analysis to create cancer classifiers is how to effectively deal with microarray data which are composed of high-dimensional attributes (p) and low-dimensional instances (n). Gene selection and classifier construction are two key issues concerned with this topics. In this article, we reviewed major methods for computational identification of cancer marker genes based on microarray gene expression data. We concluded that simple methods should be preferred to complicated ones for their interpretability and applicability.
Keywords: Cancer, computational biology, marker genes, microarrays.
Current Bioinformatics
Title:Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach
Volume: 9 Issue: 2
Author(s): Xiaosheng Wang
Affiliation:
Keywords: Cancer, computational biology, marker genes, microarrays.
Abstract: Rapid advances in gene expression microarray technology have enabled to discover molecular markers used for cancer diagnosis, prognosis, and prediction. One computational challenge with using microarray data analysis to create cancer classifiers is how to effectively deal with microarray data which are composed of high-dimensional attributes (p) and low-dimensional instances (n). Gene selection and classifier construction are two key issues concerned with this topics. In this article, we reviewed major methods for computational identification of cancer marker genes based on microarray gene expression data. We concluded that simple methods should be preferred to complicated ones for their interpretability and applicability.
Export Options
About this article
Cite this article as:
Wang Xiaosheng, Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach, Current Bioinformatics 2014; 9 (2) . https://dx.doi.org/10.2174/1574893608999140109115649
DOI https://dx.doi.org/10.2174/1574893608999140109115649 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Cell-in-cell phenomenon: A New Paradigm in Life Sciences.
Current Molecular Medicine New Developments in the Management of Pleural Effusions
Current Respiratory Medicine Reviews A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology Estrogen Receptor Beta (ERβ) Expression in Different Subtypes of Malignant Pleural Mesothelioma
Current Respiratory Medicine Reviews Filling the Gaps between the In Vivo and In Vitro Microenvironment: Engineering of Spheroids for Stem Cell Technology
Current Stem Cell Research & Therapy Targeting the Most Upstream Site of Wnt Signaling Pathway Provides a Strategic Advantage for Therapy in Colorectal Cancer
Current Drug Targets Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Ultrasound Characteristics in Complicated Ovarian Cysts
Current Women`s Health Reviews Roles of NHERF1/EBP50 in Cancer
Current Molecular Medicine The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets A New “Era” for the α7-nAChR
Current Drug Targets Distinctive Phenotype Identification for Breast Cancer Genotypes Among Hereditary Breast Cancer Mutated Genes
Current Bioinformatics Apoptosis and Apoptosis-Based Therapy in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings
Anti-Cancer Agents in Medicinal Chemistry Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets